Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE Trial
Top Cited Papers
Open Access
- 1 October 2007
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 9 (10), 1064-1069
- https://doi.org/10.1016/j.ejheart.2007.07.011
Abstract
Background: We examined the relation of maximal in‐hospital diuretic dose to weight loss, changes in renal function, and mortality in hospitalised heart failure (HF) patients. Methods: In ESCAPE, 395 patients received diuretics in‐hospital. Weight was measured at baseline, discharge, and every other day before discharge. Weight loss was defined as the difference between baseline and last in‐hospital weight. Mortality was assessed using a log‐logistic model with non‐zero background. Results: Median weight loss: 2.8kg (0.7, 6.1); mean: 3.7kg (22% of values 300mg/day. Dose remained a significant predictor of mortality after adjusting for baseline variables that significantly predicted mortality. Correlation between maximal dose and creatinine level change was not significant (r=0.043; p=0.412) Conclusions: High diuretic doses during HF hospitalisation are associated with increased mortality and poor 6‐month outcome.This publication has 13 references indexed in Scilit:
- Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization EffectivenessJAMA, 2005
- Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart FailureClassification and Regression Tree AnalysisJAMA, 2005
- Risk stratification after hospitalization for decompensated heart failureJournal of Cardiac Failure, 2004
- The severe cardiorenal syndrome: ‘Guyton revisited’European Heart Journal, 2004
- The Clinical Challenge of Cardiorenal SyndromeCirculation, 2004
- 368 Impact of intravenous diuretics on the outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE® RegistryJournal of Cardiac Failure, 2004
- Diuretic resistance predicts mortality in patients with advanced heart failureAmerican Heart Journal, 2002
- Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedemaThe Lancet, 1998
- Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failureClinical Pharmacology & Therapeutics, 1997
- Diuretic activity of torasemide and furosemide in chronic heart failure: A comparative double blind cross-over studyEuropean Journal of Clinical Pharmacology, 1986